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Binding sites for adenosine were solubilized from rat brainstem membranes with either sodium cholate, 
sodium deoxycholate or 3-[(3-choIamidopropyl)dimethyl-ammonio]-l-propanesulfonate. About 30% of 
the binding activity were released by these detergents as assayed by [‘Hlphenylisopropyladenosine (PIA) 
binding. Specific [‘HIPIA binding to the solubilized fraction was saturable and was found to be a 
monophasic saturation profile. In contrast, [3H]PIA binding to the brainstem membranes exhibited a 
biphasic profile suggesting the presence of two binding sites. By gel filtration on a Sepharose CL-6B 
column, the, adenosine binding site-detergent complex was estimated to have app. M, 280000 and 
r, = 5.4 nm. 
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1. INT.RODUCTION 
Pharmacological and biochemical studies sug- 
gest that adenosine may perform significant func- 
tions in central nervous system via adenosine- 
binding sites; i.e., adenosine receptor [l-4]. 
Elucidation of the molecular mechanisms of these 
functions requires detailed knowledge of the struc- 
tural components of the receptor system. Progress 
in purifying the receptor, however, has been 
retarded by the lack of an efficient technique for 
solubilizing adenosine receptor in adequate quan- 
tities without changing their affinities for ligands. 
Here, we have tried to separate adenosine-binding 
sites in active form from the membranes of rat 
brainstem by several detergents. Of the solubilizing 
agents, tested, sodium cholate, sodium deoxy- 
cholate and CHAPS were effective in solubilizing 
membrane-bound adenosine-binding sites. Gel 
filtration of the solubilized binding site on a 
Sepharose CL-6B column gave an M, estimate of 
- 280 000 for the binding site-detergent complex. 
A similar solubilization procedure of adenosine- 
binding sites from bovine forebrain was reported 
in [5]. 
2. MATERIALS AND METHODS 
2-l Materials 
[3H]PIA (20 Ci/mmol) and [‘HINECA (34 
Ci/mmol) were obtained from Amersham. 
[3H]CHA (13.5 Ci/mmol) was purchased from 
New England Nuclear. PIA and adenosine 
deaminase were from Boehringer and sodium 
cholate, sodium deoxycholate, Lubrol PX, 
digitonin, Tween 80 and Nonidet P-40 were from 
Nakarai Co. CHAPS was a gift of Dr. L.H. 
Hjelmeland and subsequently purchased from 
Sigma. 
Abbreviations: PIA, I@-phenylisopropyladenosine; 
CHA, N6-cyclohexyladenosine; NECA, 5 ’ -N-ethylcar- 
boxamideadenosine; CHAPS, 3-[(3-cholamidopropyl)- 
dimethyl-ammoniol-1-propanesulfonate 
2.2 Membranes 
Fresh brainstems of Wistar rats were 
homogenized in 3 vol. of 50 mM Tris-acetate buf- 
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fer (pH 7.6) containing 2 mM dithiothreitol and 1 
mM phenylmethylsulfonylfluoride with a Potter- 
Elvehjem homogenizer. The homogenate was cen- 
trifuged at 39000 x g for 30 min at 4’C and the 
resulting pellet was washed 3 times in 5 vol. same 
buffer, ice-cold. The washed pellet was suspended 
in the same buffer and incubated with 2 U/ml 
adenosine deaminase at 30°C for 30 min, followed 
by centrifugation at 39000 x g for 30 min at 4°C. 
The final pellet was suspended in 5 vol. 50 mM 
Tris-acetate buffer (pH 7.6). 
2.3 Solubilization 
To the membrane suspension (8 mg/ml) was 
added leupetin, chymostatin, antipain and 
pepstatin A to a final concentration of 10 pg/ml 
each. After the addition of sodium cholate and 
dithiothreitol to final concentrations of 1% and 1 
mM, respectively, the mixture was stirred for 30 
min at O”C, then centrifuged at 106 800 x g for 60 
min at 4°C. The pellet was discarded and the 
supernatant was stored at -80°C until used. 
Although the following experiments were perform- 
ed within a month, storage of the solubilized 
preparation thus obtained for several weeks led to 
- 50% loss of the binding activity. 
2.4. Binding assays 
The binding assay of membrane fractions was 
performed as follows unless otherwise indicated. 
[3H]PIA (5 nM) and brainstem membranes (-400 
pg/assay) were incubated at 37°C for 20 min in a 
0.5 ml total vol. of 50 mM Tris-acetate buffer (pH 
7.4) in the absence or presence of 80/cM PIA. The 
reaction was terminated by vacuum filtration 
through Whatman GF/C filter, the sample tube 
and the filter were washed 3 times with 5 ml ice- 
cold Tris-acetate buffer (pH 7.4) the filter was 
dried and the radioactivity was determined by a li- 
quid scintilation spectrometer. For the assay of 
solubilized fractions, incubations were carried out 
at 30°C for 90 min and separation of the bound 
ligand from the free was accomplished as in [6]. 
After incubation, bovine y-globulin and polyethyl- 
ene glycol6000 were added to the incubation mix- 
ture to final concentrations of 0.8 mg/ml and 
15070, respectively. After further incubating for 20 
min at O”C, the solution was filtered through 
Whatman GF/B filters and the filters were washed 
3 times with 5 ml 15% polyethylene glycol 6000, 
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dried, and analyzed for radioactivity. Specific 
binding was defined as radioactivity bound after 
subtraction non-specific binding assayed in the 
presence of 80 pM PIA. 
2.5. Protein ashy 
Protein was determined as in [7] with bovine 
serum albumin as a standard. 
3. RESULTS AND DISCUSSION 
Of the solubilizing agents tested, sodium 
cholate, sodium deoxycholate and CHAPS were 
effective in releasing [‘HIPIA-binding activity 
Table 1 
Solubilization of [‘H]PIA-binding sites of rat brainstem 
membranes by various detergents 
Treatment 
(%) 
% Protein 070 Binding sites 
solubilized solubilized 
Cholate (1) 37 30 
Deoxycholate (0.2) 20 15 
Triton X-100 (1) 30 0 
Digitonin (1) 17 0 
Nonidet P-40 (1) 33 0 
Lubrol PX (5) 50 4 
Brij 35 (1%) 9 1 
Tween 80 (1) 15 0 
CHAPS (1.5) 34 32 
The membrane fraction of rat brainstem (8 mg/ml) was 
incubated in 50 mM Tris-acetate buffer @H 7.4) con- 
taining 1 mM dithiothreitol, protease inhibitors and the 
indicated detergents for 30 min at O”C, and then cen- 
trifuged at 106 800 x g for 60 min at 4°C. The superna- 
tant was used for the binding assay 
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Fig. 1. Time course of PIA-binding activity of rat 
brainstem membrane (A) and the membrane solubilized 
with cholate (B). Incubations were done as in section 2 
but for the indicated times at the indicated temperatures. 
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Fig. 2. Effect of pH on PIA-binding activity of rat 
brainstem membrane (0) and the membrane solubilized 
with cholate (0). Incubations were performed for 20 
min at 37°C for assay of membrane preparation and for 
30 min for assay of solubilized preparation in 40 mM 
potassium phosphate buffer (pH 5.5-9). 
from rat brainstem membranes (table 1). Although 
Triton X-100, Nonidet P-40 and Lubrol PX were 
effective in solubilizing the membrane proteins but 
ineffective in solubilizing active PIA-binding ac- 
tivity. These results suggest that the molecular 
structure of cholic acid in the detergents may be 
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Fig. 3. Saturation analysis of [3H]PIA binding to rat brainstem membrane (A, B) and the membrane solubilized with 
cholate (C, D). Incubations were performed as in section 2, except that the concentration of [‘H]PIA was varied as 
indicated. Scatchard plots (B) and (D) were obtained from the data shown in (A) and (C), respectively. 
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necessary for the solubilization of adenosine- 
binding activity. 
Time course of PIA binding to the membrane 
preparation from rat brainstem and the prepara- 
tion solubilized with cholate are shown in fig. 1. 
The initial rates of PIA binding increased with an 
increase in temperature in both preparations, but 
the temperature dependence was much greater in 
the solubiized preparation than in the membrane 
preparation. The maximal extent of PIA binding 
to the membrane preparation at 37°C were the 
same as at 25°C and prolonged incubation after 
reaching a maximal evel resulted in little or no loss 
of activity (fig. 1A). In contrast, the maximal ex- 
tent of PIA binding to the solubilized preparation 
was decreased as the incubation temperature in- 
creased (1B). Thus, the PIA-binding sites appeared 
to become unstable upon solubilization. The PIA- 
binding activity of both the membrane and 
solubilized preparations were not significantly af- 
fected over pH 6-9 (fig. 2). 
Scatchard analysis of 13H]PIA binding to rat 
brainstem membranes howed the existence of 2 
distinct specific binding sites are shown in fig. 3B. 
The dissociation constants were determined to be 
1.7 and 9 nM from the slopes of the plots. The 
rn~rn~.n~bers of the high and low affinity bin- 
ding sites were estimated to be 0.28 and 0.58 
pmol/mg protein, respectively, from the intercept 
on the abscissa. Similar kinetic analysis of 
[3H]CHA and [3H]NECA binding also indicated 
the presence of two distinct binding sites (not 
shown). In contrast, Scatchard analysis of 
13H]PIA binding to the preparation solubilized 
with cholate showed a linear relationship in- 
dicating the only one species of the binding site as 
shown in fig. 3D. The dissociation constant was 
determined to be 2.7 nM, which was identical to 
that of the high affinity binding site of the mem- 
branes. Scatchard plots of f3H]CHA and 
t3H]NECA binding to the preparation solubilized 
with cholate also showed linear relationships. 
The studies of various adenosine derivatives on 
adenylate cyclase activity suggested the existence 
of at least two distinct adenosine receptors: At 
receptor mediating a decrease in adenylate cyclase 
activity and AZ receptor mediating an increase [8, 
91. In [9-l l] PIA and CHA at nM-levels were 
preferentially effective on At receptor and NECA 
to AZ receptor. However, the kinetic behavior of 
I I ? (A) 
0 
1. 
2 4 6 8 
Stokes radius (ran) 
Fig. 4. Gel filtration of solubiliied [‘HjPIA-binding sites 
on Sepharose CLdB. [-‘H]PIA (8 nM) was incubated for 
15 min at 37°C with brainstem membrane (8.mg/ml) in 
50 mM Tris-acetate buffer (PH 7.4) in the presence or 
in the absence of 80 FM PIA. After the incubation, 
sodium cholate, ~t~othreitol and protease inhibitors 
(leupeptin, chymostatin, antipain and pepstatin A) were 
added to final concentrations of l%, 1 mM and 10 
pg/m.l, respectively, followed by further incubation for 
30 min at 0°C with stirring. The mixture was centrifuged 
at 106800 x g for 60 min at 4°C and the resulting 
su~matant (1 ml) was imme~ately applied to a 
Sepharose CL-6B column (1.4 x 33 cm) equilibrated in 
50 mM Tris-acetate buffer (pH 7.4) containing 0.1% 
Triton X-100, 1 mM dithiothreitol and 0.15 M NaCl. 
When incubation was performed in the presence of 
unlabelled PIA, the radioactive peak around fraction 22 
was not observed, indicating that it may be derived from 
[SEPIA-adenosine binding site complex. Estimation of 
the Stokes radius of the adenosine-binding site by 
comparison with the marker proteins. The arrow 
indicates the position of [3H]PIA-binding site complex. 
Abbreviations: BSA, bovine serum albumin; LDH, 
lactate dehydrogenase; &Gal, E. co& &galactosidase 
[3H]NECA binding to rat brainstem membranes 
and the solubilized preparation were essentially 
similar to those of fH]PIA and [‘H]CHA binding 
under our experimental conditions. 
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